JPRN-UMIN000024011已完成未知
A Japanese, multicenter, randomized, double-blind, placebo-controlled, prospective study of AT-02 in patients with fibromyalgia - A Japanese, multicenter, randomized, double-blind, placebo-controlled, prospective study of AT-02 in patients with fibromyalgia
P-Mind Co. Ltd.0 个研究点目标入组 40 人开始时间: 2016年9月12日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Patients with expected survival less than 3 years due to malignancies or other reasons (2)Patients using life-sustaining electrical medical devices, such as artificial heart-lung devices (3)Patients using affixed electrical medical devices, such as ECG recorders (4)Patients who are participating in another clinical trial for a pharmaceutical product or medical device (5)Patients with dementia that seriously disturbs activities of daily life (6)Females who wish to become pregnant or are presently pregnant or nursing mothers (if the patient is a woman of childbearing potential, a pregnancy test must be performed) and others.
研究者
相似试验
招募中
不适用
An Asian, multicenter, randomized, double-blind, placebo controlled 14-week study of mirogabalin in patients with central neuropathic pain followed by a 52-week open-label extensioKCT0004730Daiichi-Sankyo Korea3
Unknown
不适用
TurmXtra 60N (Water dispersible Turmeric extract) capsule 250 mg in subjects with Non Alcoholic Fatty Liver Disease (NAFLD)CTRI/2020/03/023814Inventia Healthcare Limited India
进行中（未招募）
不适用
A multicenter, randomized, double-blind, two-arm, vehicle-controlled, parallel-group, two stage study to evaluate and demonstrate the efficacy and to evaluate the safety of pimecrolimus 1% cream in the treatment of seborrhoeic dermatitis in patients 12 years of age and olderSeborrhoeic Dermatitis (SD)MedDRA version: 8.1Level: LLTClassification code 10039793Term: Seborrhoeic dermatitisEUCTR2006-003984-30-DEovartis Pharma Services AG690
进行中（未招募）
不适用
A study comparing LBEC0101 to Enbrel® in subjects with active Rheumatoid Arthritis despite Methotrexate therapyDiseases of the blood and blood -forming organs and certain disorders involving the immune mechanismKCT0002163G Life Sciences372
进行中（未招募）
1 期
A Study to Evaluate the Safety and Effectiveness of APG777 in Subjects with Atopic DermatitisAtopic DermatitisCTIS2024-511260-84-00Apogee Therapeutics Inc.471